MedTrace Logo

Clevidipine in Neurocritical Patients

NCT05168059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2021-12-23

No results posted yet for this study

Summary

Acute blood pressure elevation is a frequent problem in neurocritical patients. Its effective management is challenging and must avoid significant decreases of blood pressure leading to lower cerebral perfusion pressure worsening ischemia and elevations probably associated with bleeding, rebleeding or hematoma expansion associated with poor prognosis

Conditions

Interventions

DRUG

Clevidipine 0.5 MG/ML Intravenous Emulsion

Effectiveness and safety of clevidipine

Sponsors & Collaborators

  • Biocruces Bizkaia Health Research Institute

    collaborator OTHER_GOV

  • Hospital de Cruces

    lead OTHER

Principal Investigators

  • Blanca Escontrela, Consultant · Biocruces Bizkaia Health Research Institute

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-12-31
Completion
2019-09-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05168059 on ClinicalTrials.gov